Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.

David Ross, Tamas Masszi, Maria Teresa Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentin Garcia-Gutierrez, Norbert Gattermann, Philipp Le Coutre, Bruno Martino, Susanne Saussele, Francis Giles, Jerald Radich, Guiseppe Saglio, Weiping Deng, Nancy Krunic, Veronique Bedoucha, Prashanth Gopalakrishna, Andreas Hochhaus

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.'. Together they form a unique fingerprint.

Medicine & Life Sciences